November 17, 2009Journal of the American Society of Nephrology
The Biology of the (Pro)Renin Receptor
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
PRR should not yet inform clinical RAS therapies; leaves open its pathological role pending specific antagonists and viable models.
Key Points
Key points are not available for this paper at this time.
Cite This Study
Nguyen et al. (2009) studied this question.